| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 17, 2013 | Pechala's Reports | Frantisek Pechala | BIOSANTE PHARMACEUTICALS INC (BPAX) 12-months forecast | 1 | $15 | | May 16, 2013 | New Constructs, LLC | N/A | BPAX: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: BPAX , CYTX , MNTA , NVAX , TTNP , XNPT -- DRUGS | 3 | $34.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: BIOSANTE PHARM -- BPAX | 1 | $11.50 | | May 15, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Biosante Pharmaceuticals, Inc. | 41 | $471.50 | | May 10, 2013 | S&P Capital IQ Quantitative Report | N/A | Biosante Pharmaceuticals | 5 | $57.50 | | May 4, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC | 5 | $10 | | Apr 27, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC | 5 | $10 | | Apr 6, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC | 5 | $10 |
|
View All Reports for BPAX ... |
|
|
0.01(0.87%) May 17, 3:59PM EDT